Determination of Boswellic acids in brain and plasma by high-performance liquid chromatography/tandem mass spectrometry

Analytical Chemistry

Volumn 77, Issue 20, 2005, Pages 6640-6645

  Reising, Karen ^a   Meins, Juergen ^a   Bastian, Baerbel ^a   Eckert, Gunter ^b   Mueller, Walter E ^b   Schubert Zsilavecz, Manfred ^b   Abdel Tawab, Mona ^a,b  

^a ABDA Bundesvereinigung Deutscher Apothekerverbande   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS; BRAIN; CHEMOTHERAPY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NEUROLOGY; OPTIMIZATION; PATHOLOGY; PATIENT MONITORING; PHYSIOLOGICAL MODELS;

BOSWELLIC ACIDS; NEUROLOGICAL DISORDERS; PERITUMORAL EDEMA; TANDEM MASS SPECTROMETRY;

ORGANIC ACIDS;

ARACHIDONATE 5 LIPOXYGENASE; BOSWELLIA SERRATA EXTRACT; BOSWELLIC ACID; CORTICOSTEROID; LEUKOTRIENE; PLANT EXTRACT; STEROID; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD LEVEL; BOSWELLIA; BOSWELLIA SERRATA; BRAIN; BRAIN EDEMA; BRAIN TUMOR; CALIBRATION; CONTROLLED STUDY; DRUG POTENCY; ENZYME INHIBITION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; QUANTITATIVE ANALYSIS; RAT; SWINE; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ANIMALS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; MOLECULAR CONFORMATION; PLASMA; RATS; RATS, WISTAR; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TRITERPENES;

EID: 27144482041     PISSN: 00032700     EISSN: None     Source Type: Journal    
DOI: 10.1021/ac0506478     Document Type: Article

References (19)

1. The gliomas; Berger, M. S., Wilson, C. B., Eds.; W. B. Saunders: Philadelphia, 1998.
2. Ohgaki, H.; Kleihues, P. Acta Neuropathol. 2005, 109 (1), 93-108.
3. Winking, M.; Sarikaya, S.; Rahmanian, A.; Joedicke, A.; Boeker, D.-K. J. Neurooncol. 2000, 46, 97-103.
4. Weller, M.; Schmidt, C.; Roth, W.; Dichgans, J. Neurology 1997, 48, 1704-1705.
5. Naumann, U.; Durka, S.; Weller, M. Oncogene 1998, 17, 1567-1575.
6. Ammon, H. P. T. Eur. J. Med. Res. 1996, 1, 369-370.
7. Gupta, I.; Parihar, A.; Malhotra, P.; Singh, G. B.; Luedtke, R.; Safayhi, H.; Ammon, H. P. T. Eur. J. Med. Res. 1997, 2, 37-43.
8. Safayhi, H.; Mack, T.; Sabieraj, J.; Anazado, M.; Subramannian, L. R.; Ammon, H. P. T. J. Pharmacol. Exp. Ther. 1992, 261, 1143-1146.
9. Safayhi, H.; Sailer, E. R.; Ammon, H. P. T. Mol. Pharmacol. 1995, 47, 1212-1216.
10. Sailer, E. R.; Subramannian, L. R.; Rail, B.; Hoernlein, R. F.; Ammon, H. P. T.; Safayhi, H. Br. J. Pharmacol. 1996, 117, 615-618.
11. Maskowitz, M. A.; Kiwak, K. J.; Hekimian, K.; Levine, L. Science 1984, 224, 886-889.
12. Simmet, T.; Luck, W.; Winking, M.; Delank, W. K.; Peskar, B. A. J. Neurochem. 1990, 54, 2091-2099.
13. Winking, M.; Boeker, D. K.; Simmet, T. Neurooncology 1996, 30, 39.
14. Glaser, T.; Winter, S.; Groscurth, P.; Safayhi, H.; Sailer, E. R.; Ammon, H. P.; Schabet, M.; Weller, M. Br. J. Cancer 1999, 80 (5-6), 756-765.
15. Hostanska, K.; Daum, G.; Sailer, R. Anticancer Res. 2002, 22 (5), 2853-2862.
16. Abdel Tawab, M.; Kaunzinger, A.; Bahr, U.; Karas, M.; Wurglics, M.; Schubert-Zsialvecz, M. J. Chromatogr., B 2001, 761, 221-227.
17. Kaunzinger, A.; Baumeister, A.; Cuda, K.; Haering, N.; Schug, B.; Blume, H. H.; Raddatz, K.; Fischer, G.; Schubert-Zsilavecz, M. J. Pharm. Biomed. Anal. 2002, 28, 729.
18. Buechele, B.; Simmet, T. J. Chromatogr., B 2003, 795, 355-362.
19. Shah, V.; Midha, K. K.; Findley, J. W. A.; Hill, H. M.; Hulse, J. D.; McGilveray, I. J.; McKay, G.; Miller, K. J.; Patnaik, R. N.; Powell, M. L.; Tonelli, A.; Viswanathan, C. T.; Yacobi, A. J. Pharm. Res. 2000, 17, 1551-1557.